Skip to content

Escalon Medical Corp.: 10-Q filed 2026-02-17

What Escalon Medical Corp. reported in its quarterly report filed 2026-02-17 (fiscal Q2 2026): 40 published measures, 115 facts as tagged in accession 0001628280-26-008545.

This filing

Form
10-Q (quarterly report)
Filed
2026-02-17
Fiscal period
fiscal Q2 2026
Accession
0001628280-26-008545 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Escalon Medical Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-12-314,980,001USD
At 2025-06-304,993,059USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-12-313,207,069USD
At 2025-06-303,077,952USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-12-311,772,932USD
At 2025-09-301,675,255USD
At 2025-06-301,915,107USD
At 2024-12-312,023,386USD
At 2024-09-301,777,365USD
At 2024-06-301,809,582USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-12-31337,434USD
At 2025-06-30545,835USD
At 2024-12-31520,584USD
At 2024-06-30209,033USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-10-01 to 2025-12-3197,677USD92
2025-07-01 to 2025-12-31-142,175USD184
2025-07-01 to 2025-09-30-239,852USD92
2024-10-01 to 2024-12-31246,021USD92
2024-07-01 to 2024-12-31213,804USD184
2024-07-01 to 2024-09-30-32,217USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-07-01 to 2025-12-31-432,407USD184
2024-07-01 to 2024-12-31334,270USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-07-01 to 2025-12-314,421USD184
2024-07-01 to 2024-12-310USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-07-01 to 2025-12-31-28,123USD184
2024-07-01 to 2024-12-31-22,655USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-07-01 to 2025-12-31-4,421USD184
2024-07-01 to 2024-12-310USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-12-31-68,581,526USD
At 2025-06-30-68,439,351USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-10-01 to 2025-12-317,415,329shares92
2025-07-01 to 2025-12-317,415,329shares184
2024-10-01 to 2024-12-317,415,329shares92
2024-07-01 to 2024-12-317,415,329shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-10-01 to 2025-12-3114,423,729shares92
2025-07-01 to 2025-12-317,415,329shares184
2024-10-01 to 2024-12-3114,081,616shares92
2024-07-01 to 2024-12-3114,081,616shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-10-01 to 2025-12-310.01USD/shares92
2025-07-01 to 2025-12-31-0.02USD/shares184
2024-10-01 to 2024-12-310.02USD/shares92
2024-07-01 to 2024-12-310.01USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-10-01 to 2025-12-310.01USD/shares92
2025-07-01 to 2025-12-31-0.02USD/shares184
2024-10-01 to 2024-12-310.02USD/shares92
2024-07-01 to 2024-12-310.01USD/shares184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-10-01 to 2025-12-310USD92
2025-07-01 to 2025-12-310USD184
2024-10-01 to 2024-12-310USD92
2024-07-01 to 2024-12-310USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-12-3132,427USD
At 2025-06-3034,589USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-10-01 to 2025-12-3198,738USD92
2025-07-01 to 2025-12-31-104,013USD184
2024-10-01 to 2024-12-31255,904USD92
2024-07-01 to 2024-12-31228,949USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-12-314,288,346USD
At 2025-06-304,611,937USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-12-312,602,655USD
At 2025-06-302,685,248USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-12-31992,858USD
At 2025-06-301,387,192USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-12-3119,788USD
At 2025-06-3029,792USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-12-312,237,636USD
At 2025-06-301,502,895USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-12-311,524,747USD
At 2025-06-302,142,263USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-10-01 to 2025-12-311,326,132USD92
2025-07-01 to 2025-12-312,433,527USD184
2024-10-01 to 2024-12-311,162,137USD92
2024-07-01 to 2024-12-312,261,391USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-10-01 to 2025-12-31131,182USD92
2025-07-01 to 2025-12-31347,280USD184
2024-10-01 to 2024-12-31155,940USD92
2024-07-01 to 2024-12-31296,799USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-12-317,415,329shares
At 2025-06-307,415,329shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-12-31337,434USD
At 2025-06-30802,385USD
At 2024-12-31777,070USD
At 2024-06-30465,455USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-12-3169,702,043USD
At 2025-06-3069,702,043USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-12-31576,652USD
At 2025-06-30253,953USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-12-31579,437USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-12-31748,065USD
At 2025-06-30633,422USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-10-01 to 2025-12-3143,787USD92
2025-07-01 to 2025-12-31-168,187USD184
2024-10-01 to 2024-12-31122,724USD92
2024-07-01 to 2024-12-3198,929USD184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-07-01 to 2025-12-3116,587USD184
2024-07-01 to 2024-12-3120,479USD184

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-10-01 to 2025-12-31776USD92
2025-07-01 to 2025-12-315,080USD184
2024-10-01 to 2024-12-314,883USD92
2024-07-01 to 2024-12-3110,145USD184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-285USD92
2025-07-01 to 2025-12-31-33,082USD184
2024-10-01 to 2024-12-31-5,000USD92
2024-07-01 to 2024-12-31-5,000USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-1,061USD92
2025-07-01 to 2025-12-31-38,162USD184
2024-10-01 to 2024-12-31-9,883USD92
2024-07-01 to 2024-12-31-15,145USD184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-07-01 to 2025-12-317,347USD184
2024-07-01 to 2024-12-3111,464USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-12-31673,419USD184
2024-07-01 to 2024-12-31-513,411USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-12-31-617,516USD184
2024-07-01 to 2024-12-31105,965USD184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-12-31-394,334USD184
2024-07-01 to 2024-12-31-465,440USD184

Inspect the source

Entity
Escalon Medical Corp. / CIK 0000862668
Captured
2026-09-20T04:59:43.148Z
SEC response SHA-256
1553c3790334a15d4c4528d0e1ce16eac37d12130ed9cd66f6b338c07ce2533d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000862668.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))